The treatment of advanced ovarian carcinoma with high dose, intravenous cyclophosphamide-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The treatment of advanced ovarian carcinoma with high dose, intravenous cyclophosphamide

Published:1976-03 Issue:1 Volume:4 Page:43-52
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Geisler Hans E.,Minor James R.,Eastlund Marvin E.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference5 articles.

1. Treatment of ovarian carcinoma;Bagley;New England J. Med.,1972

2. Burkitt's tumor in the United States;Cohen;Cancer,1969

3. Cyclophosphamide radiation therapy in childhood lymphosarcoma;Wollner,1969

4. Cyclophosphamide therapy in carcinoma of the breast and ovary;Coggins;Cancer Chemother. Rep. No. 15,1961

5. Chemotherapy of ovarian cancer;Smith;Cancer,1972

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High‐dose cyclophosphamide for hard‐to‐treat patients with relapsed or refractory B‐cell non‐Hodgkin's lymphoma, a phase II result;European Journal of Haematology;2020-01-28

2. Low dose cyclophosphamide: Mechanisms of T cell modulation;Cancer Treatment Reviews;2016-01

3. Initial Experience with Vincristine, Adriam-cin and Cisdichlorodiammine Platinum Combination Chemotherap- of Advanced Ovarian Carcinoma;Asia-Oceania Journal of Obstetrics and Gynaecology;2010-05-24

4. Phase I Trial of Granulocyte--Macrophage Colony-Stimulating Factor Plus High-Dose Cyclophosphamide Given Every 2 Weeks: a Cancer and Leukemia Group B Study;JNCI Journal of the National Cancer Institute;1993-08-01

5. A meta-analysis of prognostic factors in advanced ovarian cancer with median survival and overall survival (measured with the log (relative risk)) as main objectives;European Journal of Cancer and Clinical Oncology;1989-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3